InsidersTradesSigma
Track the GDR stock price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the authority of ASX. Operating in the Health Care sector, GDR has published 1 public disclosures. Market capitalisation: €7.5m. The latest transaction was disclosed on 13 May 2026 (Purchase). Among the most active insiders: Francesco Cannavo. The full history is accessible without an account.
1
Insider Decl.
n/a
Thresholds
€0
1 ops.
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,373 of 28,679 companies
72.2
score / 100
Value97
Quality48
FCF yld·
Earn yld·
EV/EBITDA3.0x
ROE-23%
Gross mgn93%
Net mgn3.8%
Debt/EBITDA2.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 May 2026
Declarations1 total
60,000 shares0.0000% mcap100.0% of flowShareASXASX:2924-03089972-3A693275
1 of 1 declaration
About GDR
GDR is a company operating in the health and pharmaceutical sector, listed on the XASX market. It focuses on the development and commercialization of innovative solutions to enhance healthcare.
